Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

Levy WC, Li Y, Reed SD, Zile MR, Shadman R, Dardas T, Whellan DJ, Schulman KA, Ellis SJ, Neilson M, O'Connor CM; HFACTION Investigators.

JACC Clin Electrophysiol. 2017 Mar;3(3):291-298. doi: 10.1016/j.jacep.2016.09.006.

2.

Management of Cardiac Electronic Device Infections: Challenges and Outcomes.

Kirkfeldt RE, Johansen JB, Nielsen JC.

Arrhythm Electrophysiol Rev. 2016;5(3):183-187. doi: 10.15420/aer.2016:21:2.

3.

Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry.

Silva KR, Albertini CM, Crevelari ES, Carvalho EI, Fiorelli AI, Martinelli M Filho, Costa R.

Arq Bras Cardiol. 2016 Sep;107(3):245-256. doi: 10.5935/abc.20160129. Epub 2016 Aug 29. English, Portuguese.

4.

Decision-Making Experiences of Patients with Implantable Cardioverter Defibrillators.

Green AR, Jenkins A, Masoudi FA, Magid DJ, Kutner JS, Leff B, Matlock DD.

Pacing Clin Electrophysiol. 2016 Oct;39(10):1061-1069. doi: 10.1111/pace.12943. Epub 2016 Sep 22.

5.

Current Management of Cardiac Implantable Electronic Device Infections by Infectious Disease Specialists.

Liang SY, Beekmann SE, Polgreen PM, Warren DK.

Clin Infect Dis. 2016 Oct 15;63(8):1072-1075. doi: 10.1093/cid/ciw431. Epub 2016 Jun 28.

6.

Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.

Green AR, Leff B, Wang Y, Spatz ES, Masoudi FA, Peterson PN, Daugherty SL, Matlock DD.

Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):23-30. doi: 10.1161/CIRCOUTCOMES.115.002053. Epub 2015 Dec 29.

7.

Attitudes of older adults with serious competing health risks toward their implantable cardioverter-defibrillators: a pilot study.

Green AR, Boyd CM, Rickard J, Gomon R, Leff B.

BMC Geriatr. 2015 Dec 23;15:173. doi: 10.1186/s12877-015-0173-2.

8.

Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.

Hess PL, Hellkamp AS, Peterson ED, Sanders GD, Al-Khalidi HR, Curtis LH, Hammill BG, Pun PH, Curtis JP, Anstrom KJ, Hammill SC, Al-Khatib SM.

Circ Arrhythm Electrophysiol. 2014 Oct;7(5):793-9. doi: 10.1161/CIRCEP.114.001455. Epub 2014 Jul 18.

9.

Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.

Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC.

Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.

10.

Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).

Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP; NCDR.

J Am Coll Cardiol. 2014 Mar 4;63(8):788-96. doi: 10.1016/j.jacc.2013.09.079. Epub 2013 Dec 11.

11.

Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention.

Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA.

JAMA. 2013 May 15;309(19):2025-34. doi: 10.1001/jama.2013.4982.

12.
13.

Non-evidence-based ICD implantations in the United States.

Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, Heidenreich PA, Hernandez AF, Curtis LH, Hammill S.

JAMA. 2011 Jan 5;305(1):43-9. doi: 10.1001/jama.2010.1915.

14.

Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.

Bilchick KC, Kamath S, DiMarco JP, Stukenborg GJ.

Circulation. 2010 Nov 16;122(20):2022-30. doi: 10.1161/CIRCULATIONAHA.110.956011. Epub 2010 Nov 1.

15.

Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.

Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR; National Cardiovascular Data Registry.

J Am Coll Cardiol. 2010 Aug 31;56(10):766-73. doi: 10.1016/j.jacc.2010.05.025.

16.

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.

Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH.

Circulation. 2009 Sep 8;120(10):835-42. doi: 10.1161/CIRCULATIONAHA.108.816884. Epub 2009 Aug 24.

17.

Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM.

JAMA. 2009 Apr 22;301(16):1661-70. doi: 10.1001/jama.2009.547.

Supplemental Content

Support Center